Biennial CEM in Women With a Personal History of Breast Cancer
Recruiting
N/A
Interventional Study
Breast Cancer
Breast Neoplasms
Breast Cancer Female
Neoplasms
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 30 – 79
- Sex
- Female
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 1,600 (estimated)
- Sponsor
- Wendie Berg · Other
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This is a prospective clinical trial that will examine if biennial contrast-enhanced mammography added to annual 3D mammography (tomosynthesis) substantially improves breast cancer detection with minimal increase in false-positives, in women with a personal history of breast cancer.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Asymptomatic women, ages 30-79, with a personal history of breast cancer who are at least one year out from any breast cancer surgery and/or treatment and are scheduled to have a routine annual mammogram with tomosynthesis (DBT).
Exclusion Criteria:
* Women with a history of…
Contacts